Skip to main content

Table 4 Monitoring laboratory variables in the study groups at baseline and end of the trial

From: The effects of adjunctive treatment with l-carnitine on monitoring laboratory variables in ICU patients: a double-blinded randomized controlled clinical trial

Variable

Intervention (n=24)

Placebo (n=27)

P-value*

Baseline mean (SD)

End of the trial mean (SD)

P-value

Mean difference (SEa)

Baseline

End of trial

P-value#

Mean difference ± SE

WBC

11.54 (10.69)

10.69 (4.90)

0.599

−0.85 (7.84)

10.14 (4.53)

11.50 (5.48)

0.191

1.36 (5.24)

0.450

Hb

10.18 (2.39)

10.00 (2.28)

0.635

−0.18 (0.36)

9.60 (1.69)

9.42 (1.82)

0.539

−0.18 (0.29)

0.660

PLT

219.54 (142.56)

239.88 (101.49)

0.539

20.34 (32.57)

203.74 (91.10)

256.92 (175.1)

0.076

53.18 (28.76)

0.551

PT

15.40 (5.75)

14.43 (4.00)

0.323

−0.97 (0.96)

15.30 (4.55)

14.84 (4.46)

0.680

−0.45 (1.07)

0.685

PTT

32.87 (6.98)

32.30 (7.66)

0.753

−0.57 (1.78)

46.29 (43.46)

35.47 (12.55)

0.222

−10.83 (8.66)

0.332

INR

1.44 (0.72)

1.29 (0.44)

0.248

−0.14 (0.12)

1.39 (0.54)

1.55 (0.83)

0.101

0.16 (0.10)

0.049

FBG

141.79 (64.53)

113.13 (56.38)

0.072

−28.67 (15.20)

122.85 (59.11)

137.11 (75.55)

0.358

14.26 (15.23)

0.128

BUN

70.58 (63.80)

55.13 (52.60)

0.187

−15.46 (11.38)

66.26 (39.18)

61.11 (41.80)

0.569

−5.1 (8.93)

0.508

Cr

1.37 (0.83)

1.00 (0.37)

0.028

−0.36 (0.16)

1.53 (0.76)

1.69 (1.07)

0.345

0.16 (0.17)

0.005

Na

139.29 (9.59)

136.33 (3.76)

0.113

−2.96 (1.79)

137.56 (7.71)

136.33 (4.51)

0.428

−1.22 (1.52)

0.815

K

3.97 (0.48)

3.85 (0.51)

0.465

−0.12 (0.16)

3.77 (0.60)

5.36 (7.38)

0.272

1.59 (1.42)

0.305

Ca

8.33 (0.89)

8.56 (1.03)

0.270

0.23 (0.20)

8.59 (0.50)

8.18 (1.06)

0.031

−0.4 (0.18)

0.044

Mg

2.09 (0.34)

2.14 (0.54)

0.694

0.05 (0.13)

2.19 (0.60)

2.16 (0.60)

0.882

−0.02 (0.16)

0.917

PH

3.30 (1.44)

3.43 (1.06)

0.654

0.14 (0.30)

3.43 (1.15)

3.93 (1.78)

0.181

0.51 (0.37)

0.263

ALT (SGPT)

41.42 (37.65)

19.88 (16.34)

0.003

−21.54 (6.55)

53.53 (68.13)

49.19 (55.30)

0.735

−4.3 (12.67)

0.022

AST (SGOT)

52.88 (46.50)

31.75 (30.20)

0.020

−21.13 (8.46)

55.54 (59.06)

44.74 (29.07)

0.349

−10.80 (11.33)

0.119

Total bilirubin

1.24 (0.81)

0.87 (0.60)

0.026

−0.37 (0.15)

0.63 (0.21)

0.69 (0.49)

0.512

0.06 (0.09)

0.833

Direct bilirubin

0.57 (0.45)

0.45 (0.35)

0.092

−0.12 (0.07)

0.29 (0.13)

0.33 (0.30)

0.494

0.04 (0.06)

0.868

Lactate

12.93 (6.28)

8.96 (6.95)

0.013

−3.97 (1.48)

10.71 (4.38)

15.72 (6.66)

0.001

5.01 (1.33)

<0.001

Alb

3.05 (0.40)

3.71 (0.62)

<0.001

0.66 (0.14)

3.12 (0.48)

3.13 (0.66)

0.912

0.01 (0.13)

0.001

Total protein

5.11 (0.74)

5.74 (0.69)

0.001

0.63 (0.16)

5.16 (1.07)

5.14 (1.05)

0.904

−0.02 (0.15)

0.003

  1. aStandard error
  2. #Obtained from paired T-test
  3. *Obtained from analysis of covariance (ANCOVA), the mean values of outcomes were compared between groups, and adjustment was made for baseline values of compared outcomes